CH₃CH₃

Paul Janssen

1926–2003 · Belgian · Janssen Pharmaceutica, Beerse, Belgium (founded 1953; later a Johnson & Johnson subsidiary)

Paul Janssen was a Belgian physician and pharmacologist who founded Janssen Pharmaceutica in 1953 and ran its research for four decades. He worked by systematic structure-activity variation of known scaffolds — pethidine for the opioids, the butyrophenones for the antipsychotics, imidazoles for the antifungals — and the company that grew around that method registered more than eighty medicines, four of them on the WHO Essential Medicines list. Haloperidol and fentanyl, both from his own hand in 1958-1960, are the two that reshaped their fields; fentanyl in particular went on to become the template for the illicit synthetic-opioid market decades after his death. He died in Rome in 2003 while attending a Pontifical Academy of Sciences meeting.

Compounds credited overall: More than 80 marketed medicines came out of Janssen Pharmaceutica in his lifetime; he is named on over 100 patents and co-authored roughly 850 papers. Only the earliest of those compounds are his own bench work — from the early 1960s onward he directed a medicinal-chemistry group and is typically the senior author rather than the synthetic chemist.

Wikipedia

Compounds

Sort

25 credited across 13 classes · 23 with a page here

  • Adulterants & Cutting Agents
  • Levamisole C11H12N2S first synthesis, 1966 source

    Careful attribution: Janssen's team made the RACEMATE, tetramisole (code R 8299), reported in Nature and J Med Chem in 1966 with Janssen as senior author. Levamisole is the levorotatory enantiomer, and the resolution of dl-tetramisole was published in 1968 by Bullock, Hand and Waletzky at American Cyanamid (https://pubmed.ncbi.nlm.nih.gov/5637168/). So the scaffold and the anthelmintic discovery are Janssen's lab; the single-enantiomer drug as such is not cleanly his. Its presence on this site is as a cocaine adulterant, which has nothing to do with either group.

  • Anthelmintics
  • Mebendazole first synthesis, 1971 source

    Janssen Pharmaceutica under his direction. Year is the first clinical reports (code R 17 635, so the compound dates from the late 1960s); the benzimidazole-carbamate chemistry was published later, in 1978, by Raeymaekers, Van Gelder, Roevens and Janssen. On the WHO Essential Medicines list. Family name is invented.

  • Antiemetics
  • Domperidone C22H24ClN5O2 first synthesis, 1974 source

    Janssen Pharmaceutica under his direction (code R 33 812), designed out of the antipsychotic work as a dopamine antagonist that does not cross the blood-brain barrier. Janssen is senior author on the 1978 papers introducing it.

  • Cisapride C23H29ClFN3O4 first synthesis, 1980 source

    Janssen Pharmaceutica under his direction (code R 51 619); Janssen is senior author on the 1985 characterisation paper, chemistry by P.G.H. Van Daele. Withdrawn from most markets around 2000 for QT prolongation. Filed under Antiemetics as the nearest family to a gastroprokinetic.

  • Antifungals
  • Miconazole C18H14Cl4N2O first synthesis, 1969 source

    Janssen Pharmaceutica under his direction: the bench chemistry was by E.F. Godefroi and Jan Heeres, with Janssen as senior author on the 1969 J Med Chem paper (patented 1968). This paper is the start of the whole Janssen azole antifungal line. Family name is invented — the site has no antifungal family.

  • Ketoconazole C26H28Cl2N4O4 first synthesis, 1976 source

    Janssen Pharmaceutica under his direction only — the chemistry paper (J Med Chem 1979) is Jan Heeres, Leo Backx, J.H. Mostmans and Jan Van Cutsem, without Janssen as an author. The first orally active broad-spectrum antifungal; patented 1977, US introduction 1981. Family name is invented.

  • Itraconazole C35H38Cl2N8O4 first synthesis, 1984 source

    Janssen Pharmaceutica under his direction (code R 51 211), first described in 1984 with Janssen as senior author; chemistry from the Heeres/Backx group that made ketoconazole. Wikipedia's infobox gives a 1978 patent year, which does not fit the R-number or the literature — treat the date as approximate. Family name is invented.

  • Antihistamines
  • Astemizole C28H31FN4O first synthesis, 1981 source

    Janssen Pharmaceutica under his direction; bench chemistry by F. Janssens and colleagues with Paul Janssen as senior author (J Med Chem 1985), first pharmacology 1981, marketed 1983 as Hismanal. Withdrawn 1999 for cardiac arrhythmia. Year given is first publication, not necessarily synthesis.

  • Antispasmodics
  • Ambucetamide first synthesis, 1953 source

    Janssen personally. An antispasmodic for menstrual cramps, and the first compound of the newly founded company (Janssen code R 5). Sourcing is thin — Wikipedia-level only — so the personal attribution is likely but not independently confirmed.

  • Atypical
  • Risperidone C23H27FN4O2 first synthesis, 1988 source

    Janssen Pharmaceutica under his direction, not his own bench work. Code R 64 766, made in the mid-1980s and first described in 1988 with Janssen as first author of the pharmacology paper; the year given is that first description, not a confirmed synthesis date. He described its design himself as the line running from haloperidol through pipamperone and ketanserin to a combined 5-HT2/D2 antagonist. Approved in the US in 1993.

  • Fentanyls
  • Fentanyl C22H28N2O first synthesis, 1960 source

    Janssen personally, code R 4263, from the same pethidine-variation programme that gave phenoperidine; marketed as Sublimaze from 1963. Date has a genuine split in the sources: the anaesthesia literature (Stanley, and the December-1960 R-number sequence) says 1960, English Wikipedia says 1959. The compound's later role as the backbone of the illicit synthetic-opioid supply is entirely posthumous to his work.

  • Carfentanil C24H30N2O3 first synthesis, 1974 source

    Made by a team of Janssen Pharmaceutica chemists that included Paul Janssen — not solely his work. Part of the 4-anilinopiperidine series reported by Van Bever, Niemegeers, Schellekens and Janssen in 1976; originally a large-animal immobilising agent (Wildnil).

  • Sufentanil C22H30N2O2S first synthesis, 1974 source

    Janssen Pharmaceutica under his direction; Janssen is senior author on the 1976 papers introducing it (code R 33 799, marketed as Sufenta from 1979). The bench chemistry in that series is W.F.A. Van Bever's.

  • Alfentanil C21H32N6O3 first synthesis, 1976 source

    Discovered at Janssen Pharmaceutica under his direction; no source found that names him as the individual synthetic chemist. Short-acting, marketed as Rapifen from 1983.

  • Lofentanil C25H32N2O3 first synthesis, 1976 source

    Janssen Pharmaceutica under his direction, from the same 1976 Van Bever/Janssen 4-anilinopiperidine series as carfentanil and sufentanil. Never marketed; year is the publication of the series, not necessarily the synthesis.

  • General Anaesthetics
  • Etomidate C14H16N2O2 first synthesis, 1964 source

    Janssen Pharmaceutica under his direction (code R 16659); Janssen is first author on the 1971 paper introducing it. Still a standard induction agent for haemodynamically unstable patients. Family name is invented — the site's vocabulary has no general-anaesthetic bucket.

  • Open-chain Opioids
  • Dextromoramide C25H32N2O2 first synthesis, 1956 source

    Janssen personally, with A.H. Jageneau; Janssen is first author on the 1957 paper introducing the series (company code R 875, marketed as Palfium). One of the compounds that established his structure-activity method before the company had a chemistry department of any size.

  • Piritramide C27H34N4O first synthesis, 1961 source

    Janssen is the sole author of the 1961 paper introducing it (as 'pirinitramide', code R 3365). Still used as a post-operative analgesic in Belgium, Germany and the Netherlands.

  • Phenylpiperidines
  • Diphenoxylate C30H32N2O2 first synthesis, 1956 source

    Janssen personally, as part of his pethidine-variation programme; the peripherally-acting antidiarrhoeal use came out of screening opioids for gut effects. Later sold as Lomotil.

  • Phenoperidine C23H29NO3 first synthesis, 1957 source

    Janssen personally. Made by replacing the N-methyl of pethidine with a phenylhydroxypropyl group; roughly 100x pethidine in animals. This is the compound directly upstream of fentanyl in his SAR series.

  • Loperamide C29H33ClN2O2 first synthesis, 1969 source

    Credited to Janssen personally in 1969; the published chemistry (J Med Chem 1973, code R 18 553) is by R.A. Stokbroekx and colleagues with Janssen as senior author, so 'his hand plus his group' is the honest reading. Marketed as Imodium from 1973.

  • Serotonin Antagonists
  • Ketanserin C22H22FN3O3 first synthesis, 1980 source

    Janssen Pharmaceutica under his direction; code R 41 468, first described in the 1981 Life Sci paper by Leysen, Awouters, Kennis, Laduron, Vandenberk and Janssen. The first selective 5-HT2A antagonist, and the pharmacological tool behind the later 5-HT2/D2 antipsychotic idea. Family name is invented.

  • Typical
  • Haloperidol C21H23ClFNO2 first synthesis, 1958 source

    Janssen personally; company code R 1625, made 11 February 1958 and in Belgian clinical trials the same year. He is first author on the 1959 J Med Pharm Chem paper reporting the synthesis and screening of the butyrophenone series. Still on the WHO Essential Medicines list.

  • Droperidol C22H22FN3O2 first synthesis, 1961 source

    Janssen Pharmaceutica under his direction, not identifiably his own bench work. A butyrophenone from the haloperidol series, used as an antiemetic and, with fentanyl, in neuroleptanalgesia.

  • Pimozide C28H29F2N3O first synthesis, 1963 source

    Janssen Pharmaceutica under his direction. A diphenylbutylpiperidine, long-acting orally; Janssen is first author on all three 1968 papers characterising it. Later an orphan-drug approval for Tourette's syndrome.

Books

Reading

Tell us something